Annovis Bio (ANVS) said on Tuesday it restored compliance with NYSE listing standards. – The company received an NYSE deficiency notice on March 26, 2025, after its average global market capitalization and equity fell below $50M. – The NYSE approved the company’s remediation…
an on June 19, 2025, providing an 18-month period to regain compliance. – Annovis took corrective measures to restore its market capitalization and equity above required levels, leading the NYSE to confirm compliance. – Shares +3.72%